Brokers and consultants

We know about the high prices for new drugs, but drug companies make most of their money from repeated small price increases on older drugs.

Learn what’s at stake for pharmacy benefits sponsors as federal oversight changes and state legislative sessions begin.

Hear how PBMs negotiate to deliver the lowest possible cost, benefiting plan sponsors and members alike.

As legislation impacting PBMs ramps up again at the state level, the Trump administration signs drug pricing executive order in Washington, D.C.